Overexpression of the Anti-Adhesin Podocalyxin Is an Independent Predictor of Breast Cancer Progression
暂无分享,去创建一个
D. Huntsman | C. Gilks | L. Prentice | C. Gilks | K. Gelmon | S. Chia | C. Roskelley | D. Kershaw | J. Nielsen | K. McNagny | N. Makretsov | Leah M Prentice | A. Somasiri | M. McCoy | Marcia L. McCoy | Julie S. Nielsen | David G Huntsman | Stephen K. L. Chia | Karen A Gelmon | Marcia L Mccoy | David B. Kershaw
[1] D. Huntsman,et al. Tissue microarray analysis of neuroendocrine differentiation and its prognostic significance in breast cancer. , 2003, Human pathology.
[2] W. DeWolf,et al. Human embryonal carcinoma tumor antigen, Gp200/GCTM-2, is podocalyxin. , 2003, Biochemical and biophysical research communications.
[3] Ash A. Alizadeh,et al. Software tools for high-throughput analysis and archiving of immunohistochemistry staining data obtained with tissue microarrays. , 2002, The American journal of pathology.
[4] C Blake Gilks,et al. Assessment of interlaboratory variation in the immunohistochemical determination of estrogen receptor status using a breast cancer tissue microarray. , 2002, American journal of clinical pathology.
[5] Yudong D. He,et al. Gene expression profiling predicts clinical outcome of breast cancer , 2002, Nature.
[6] A. Cleton-Jansen. E-cadherin and loss of heterozygosity at chromosome 16 in breast carcinogenesis: different genetic pathways in ductal and lobular breast cancer? , 2001, Breast Cancer Research.
[7] J. Rosen,et al. Persistent changes in gene expression induced by estrogen and progesterone in the rat mammary gland. , 2001, Molecular endocrinology.
[8] M. Farquhar,et al. Loss of glomerular foot processes is associated with uncoupling of podocalyxin from the actin cytoskeleton. , 2001, The Journal of clinical investigation.
[9] T. Graf,et al. Anuria, Omphalocele, and Perinatal Lethality in Mice Lacking the Cd34-Related Protein Podocalyxin , 2001, The Journal of experimental medicine.
[10] A. Stemmer-Rachamimov,et al. NHE-RF, a merlin-interacting protein, is primarily expressed in luminal epithelia, proliferative endometrium, and estrogen receptor-positive breast carcinomas. , 2001, The American journal of pathology.
[11] M. Farquhar,et al. Expression of podocalyxin inhibits cell-cell adhesion and modifies junctional properties in Madin-Darby canine kidney cells. , 2000, Molecular biology of the cell.
[12] Y. Chen,et al. Comparative genomic hybridization analysis of 38 breast cancer cell lines: a basis for interpreting complementary DNA microarray data. , 2000, Cancer research.
[13] C. Sassetti,et al. Identification of Endoglycan, a Member of the CD34/Podocalyxin Family of Sialomucins* , 2000, The Journal of Biological Chemistry.
[14] H. Höfler,et al. Extensive ductal carcinoma In situ with small foci of invasive ductal carcinoma: Evidence of genetic resemblance by CGH , 2000, International journal of cancer.
[15] A. Miettinen,et al. Podocalyxin in rat platelets and megakaryocytes. , 1999, The American journal of pathology.
[16] R. Wiggins,et al. Assignment of the human podocalyxin-like protein (PODXL) gene to 7q32-q33. , 1997, Genomics.
[17] M. Mann,et al. Thrombomucin, a Novel Cell Surface Protein that Defines Thrombocytes and Multipotent Hematopoietic Progenitors , 1997, The Journal of cell biology.
[18] R. Wiggins,et al. Molecular Cloning and Characterization of Human Podocalyxin-like Protein , 1997, The Journal of Biological Chemistry.
[19] R. Wiggins,et al. Molecular Cloning, Expression, and Characterization of Podocalyxin-like Protein 1 from Rabbit as a Transmembrane Protein of Glomerular Podocytes and Vascular Endothelium * , 1995, The Journal of Biological Chemistry.
[20] D. Kerjaschki,et al. Identification and characterization of podocalyxin--the major sialoprotein of the renal glomerular epithelial cell , 1984, The Journal of cell biology.